Physician
Gastroenterology
Dr. Fred F. Poordad, MD
|
|
Give Review
Fred Poordad works in the field of Gastroenterology. He received awards:"America's Top Doctors" and "Top Doctors:Southern California". Fred Poordad is also published. He has 25 publications published. The lastest publication: "Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Sustained virologic response of 100% in HCV genotype 1b patients with Cirrhosis receiving ombitasvir/paritaprevir/r and dasabuvir for 12weeks.
- Hepatitis C Therapy: Simple for the Patient, not so Simple for the Clinician.
- Interferon-free, direct-acting antiviral therapy for chronic Hepatitis C.
- Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia.
- Low Relapse Rate Leads to High Concordance of Sustained Virologic Response (SVR) at 12 Weeks With SVR at 24 Weeks After Treatment With ABT-450/Ritonavir, Ombitasvir, a...
- Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and Cirrhosis.
- Exploratory Trial of Ombitasvir and ABT-450/r With or Without Ribavirin for HCV Genotype 1, 2, and 3 Infection.
- ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with Cirrhosis.
- Retreatment of HCV with ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin.
- Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV-HIV Coinfected Liver Transplant Recipients.
- Infections During Peginterferon/Ribavirin Therapy Are Associated With the Magnitude of Decline in Absolute Lymphocyte Count: Results of the IDEAL Study.
- Phase 2b trial of interferon-free therapy for Hepatitis C virus genotype 1.
- Boceprevir for Chronic HCV Genotype 1 Infection in Patients with Prior Treatment Failure to Peginterferon/Ribavirin, including Prior Null Response.
- Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 Hepatitis C virus infect...
- Eltrombopag Increases Platelet Numbers in Thrombocytopenic Patients with HCV Infection and Cirrhosis, Allowing for Effective Antiviral Therapy.
- Boceprevir plus peginterferon α-2b/ribavirin in chronic Hepatitis C genotype 1: impact of baseline viral load on sustained virologic response.
- Once-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-Naïve genotype 1 Hepatitis C: The randomized PILLAR study.
- Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients with Chronic HCV Genotype 1 Infection-a Randomized Trial.
- Adherence to assigned dosing regimen and sustained virological response among chronic Hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2...
- A global view of Hepatitis C: Physician knowledge, opinions, and perceived barriers to care.
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 Hepatitis C infection: a rand...
- A Phase 2a Trial of 12-Week Interferon-Free Therapy with Two Direct-Acting Antivirals (ABT-450/r, ABT-072) and Ribavirin in IL28B C/C Patients with Chronic Hepatitis C...
- Exploratory study of oral combination antiviral therapy for Hepatitis C.
- Lorcaserin Use in the Management of Morbid Obesity in a Pre-Liver Transplant Patient.
Schools
University of Alberta
Northeastern Ohio University College of Medicine
Johns Hopkins University School of Medicine
University Of South Carolina SomPalmetto Health Richland Hospital
Procedures Preformed
- Liver Biopsy
- Liver Test
- Liver Transplant
Conditions Treated
- Abdominal Pain
- Anemia
- Ascites
- Autoimmune Liver Diseases
- View All
Doctors Specialties
- Gastroenterology
- Hepatology
- Transplant Hepatology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:Southern California
Education
-
University of Alberta Faculty of Medicine
Drug Facts
| NPI NUMBER | 1174551766 | |
| NPPES Provider LastName | POORDAD | |
| NPPES Provider FirstName | FRED | |
| NPPES Provider ZIPCode | 782151612 | |
| NPPES Provider State | TX | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 497.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 6.64 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174551766 |
| Last Name Of The Provider | POORDAD |
| First Name Of The Provider | FRED |
| View All |
Similar Doctors
|
Dr. Madhavi Rudraraju, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Gary S. Gossen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Omer Junaidi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Garcia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Otero, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Donna M. McMyler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erin Barth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amit Goyal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Julio A. Gutierrez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles W. Randall, MD |
|
|
Dr. Kevin J. Franklin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Linder, MD |